Findings support ProAL50 as a biologically informative, protein-based surrogate of AL for research use that complements traditional AL, pending further external validation and assay standardization.
Abstract
Background: Chronic stress contributes to the development of cardiometabolic, malignant, and other chronic diseases through cumulative multisystem physiological dysregulation, conceptualized as allostatic load (AL). However, traditional AL relies on heterogeneous clinical biomarkers that are frequently unavailable or inconsistently collected in large cohorts, limiting reproducibility and translational utility. We developed and validated ProAL50, a proteomics-based measure of AL derived from 50 circulating proteins. Methods: Using high-dimensional plasma proteomic data from the UK Biobank, we constructed ProAL50 via penalized regression and stability selection and externally validated its construct in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Results: Among 37,089 UK Biobank participants, ProAL50 correlated strongly with traditional AL in the held-out test set (r = 0.72) and showed moderate external construct validity in CARDIA (r = 0.62). ProAL50 closely mirrored traditional AL in its associations with sociodemographic characteristics, lifestyle behaviors, physical and mental health, inflammation, and biological aging, supporting construct validity. In prospective analyses, ProAL50 showed associations with incident chronic disease, including type 2 diabetes, ischemic heart disease, chronic lung disease, chronic liver disease, chronic kidney disease, overall cancer, and all-cause and cause-specific mortality that were broadly comparable to traditional AL. Representative associations included incident type 2 diabetes (HR per SD = 2.72, 95% CI 2.61–2.84) and chronic liver disease (HR = 2.12, 95% CI 1.96–2.29). Conclusions: These findings support ProAL50 as a biologically informative, protein-based surrogate of AL for research use that complements traditional AL, pending further external validation and assay standardization.
Allostatic load (AL) is a multisystem index of physiological dysregulation due to chronic stress. Although widely applied, its operationalization remains inconsistent, limiting reproducibility and equity. Streamlined indices based on common biomarkers may enhance feasibility across settings. Using data from 150 293 pos...
C. Cirovic, Paul A. Fishman, Ramon Casanova et al.· American Journal of Epidemio...· 0 citations
PIS provides a compact, interpretable proteomic measure of inflammaging and captures mortality, multisystem disease burden, and aging-related biology in population-scale cohorts.
Robust associations were observed between depression, as a proxy measure of stress, with high allostatic load, supporting its validity as a clinically actionable biomarker of physiological and psychological dysregulation within an understudied population.
Zoe L. Walts, M. Rosenkranz, A. Letocha et al.· GeroScience· 0 citations
Abstract Background : Visceral adipose tissue (VAT) is strongly associated with cardiometabolic disease, but the network architecture connecting visceral adiposity to systemic inflammatory proteins and cardiometabolic traits remains poorly characterized. Methods : We applied an artificial intelligence (AI)-driven netwo...
Aim: Allostatic load (AL) is a composite measure of cumulative physiological stress, but its role in heart failure (HF) onset and prognosis remains unclear. Methods: We analyzed data from two U.S. cohorts. Logistic regression assessed AL and incident HF in 3,814 adults from the Health and Retirement Study (HRS, 2016–20...
Y. Nan, Haofeng Zhang, F. He et al.· Exploration of Cardiology· 0 citations
This review synthesizes current evidence on proteomic biomarkers across major physiological systems, including the immune, metabolic/endocrine, cardiovascular, musculoskeletal, and nervous systems, and highlights shared molecular signatures that underpin multisystem decline.
Ying Luo, Yu-Lin Xiao, Jie-Hua Chen et al.· Frontiers in Aging· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.